ARCT vs ROST · rev $5.0M vs P/E 21, rev $22.75B
Arcturus Therapeutics Holdings Inc (ARCT) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. Revenue was up 7.7% from 2025-02-01 to 2026-01-31. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
ARCT currently screens at market cap $369.4M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the ARCT and ROST stock pages for the full models.
Not investment advice.